Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
15.97
Jul 24 • 3:59 PM ET Dollar change-0.54 Percentage change(-3.27%)
Aftermarket Close
16.10
Aftermarket • 7:34 PM ET Dollar change+0.13 Percentage change(0.81%)
Index
-
Market Cap
640.88M
Enterprise Value
588.70M
Income
8.82M
Sales
56.60M
Book/sh
1.89
Cash/sh
1.47
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
129
IPO
Apr 17, 2019
P/E
71.39
Forward P/E
33.04
PEG
0.76
P/S
11.32
P/B
8.43
P/C
10.88
P/FCF
49.91
EV/EBITDA
79.55
EV/Sales
10.40
Quick Ratio
3.04
Current Ratio
3.34
Debt/Eq
0.09
LT Debt/Eq
0.07
Option/Short
Yes / Yes
EPS (ttm)
0.22
EPS next Y
0.48
EPS next Q
0.07
EPS this Y
70.37%
EPS next Y
57.61%
EPS next 5Y
43.33%
EPS past 3/5Y
- -
Sales past 3/5Y
24.82% 18.84%
EPS Y/Y TTM
109.31%
Sales Y/Y TTM
30.18%
EPS Q/Q
186.43%
Sales Q/Q
34.97%
Insider Own
26.55%
Insider Trans
0.00%
Inst Own
16.41%
Inst Trans
-0.67%
ROA
8.12%
ROE
12.64%
ROIC
10.84%
Gross Margin
75.51%
Oper. Margin
10.21%
Profit Margin
15.58%
SMA20
3.89%
SMA50
5.97%
SMA200
30.81%
Trades
Shs Outstand
40.03M
Shs Float
29.48M
52W High
17.35 -7.97%
52W Low
5.68 181.34%
Volatility
6.39% 4.89%
ATR (14)
0.83
RSI (14)
55.93
Beta
1.23
Rel Volume
2.37
Avg Volume
124.63K
Volume
295,166
Perf Week
1.53%
Perf Month
10.90%
Perf Quarter
1.40%
Perf Half Y
32.04%
Perf YTD
67.93%
Perf Year
169.76%
Perf 3Y
1259.15%
Perf 5Y
253.71%
Perf 10Y
-
Prev Close
16.51
Price
15.97
Change
-3.27%
Date Action Analyst Rating Change Price Target Change
Jul-20-26Initiated BTIG Research Buy $18
Nov-16-23Downgrade Raymond James Outperform → Mkt Perform
Mar-03-22Initiated Loop Capital Buy $15
Jul-19-21Initiated H.C. Wainwright Buy $17
Apr-20-21Initiated Northland Capital Outperform $15
May-13-19Initiated Raymond James Outperform $14
May-13-19Initiated Oppenheimer Outperform
May-13-19Initiated Ladenburg Thalmann Buy
May-13-19Initiated Cantor Fitzgerald Overweight $17
Jul-20-26 07:30AM
Jul-16-26 07:30AM
Jun-29-26 07:30AM
Jun-22-26 07:30AM
Jun-09-26 07:30AM
07:30AM Loading…
May-18-26 07:30AM
May-13-26 07:02PM
07:30AM
Apr-29-26 08:00AM
Apr-15-26 07:30AM
Apr-14-26 08:02PM
Apr-13-26 08:03PM
08:00AM
Mar-26-26 07:30AM
Mar-19-26 07:30AM
03:01PM Loading…
Mar-11-26 03:01PM
07:30AM
Mar-10-26 09:24AM
Mar-05-26 09:30AM
Mar-04-26 07:30AM
Feb-25-26 08:00AM
Feb-23-26 08:00AM
Feb-19-26 07:30AM
Feb-18-26 07:30AM
Feb-17-26 07:30AM
Jan-21-26 07:30AM
Jan-12-26 07:30AM
Jan-07-26 07:30AM
Dec-23-25 12:07PM
Dec-22-25 07:30AM
10:12AM Loading…
Dec-02-25 10:12AM
Nov-25-25 07:30AM
Nov-17-25 07:30AM
Nov-13-25 06:00AM
Nov-11-25 04:01PM
07:30AM
Nov-10-25 07:21AM
Nov-07-25 09:40AM
Nov-04-25 08:00AM
Oct-28-25 09:15AM
08:00AM
Oct-27-25 07:30AM
Oct-21-25 09:40AM
08:28AM
Sep-26-25 01:29PM
Sep-17-25 10:41AM
Sep-16-25 08:30AM
Aug-22-25 01:30PM
Aug-21-25 09:32AM
07:30AM
Aug-20-25 09:15AM
07:30AM
Aug-19-25 09:40AM
09:15AM
Aug-18-25 12:20PM
09:55AM
Aug-13-25 07:30AM
Aug-12-25 09:25AM
Jul-30-25 09:02AM
08:00AM
Jul-22-25 08:07AM
Jul-15-25 08:50AM
Jun-26-25 08:36AM
Jun-24-25 09:55AM
08:54AM
Jun-19-25 09:40AM
Jun-12-25 09:15AM
Jun-11-25 07:30AM
Jun-10-25 08:50AM
08:00AM
Jun-05-25 09:55AM
Jun-04-25 07:30AM
May-29-25 12:20PM
May-20-25 09:55AM
May-13-25 07:30AM
May-12-25 09:31AM
May-01-25 08:00AM
Apr-29-25 08:00AM
Apr-02-25 03:26PM
Mar-18-25 03:04PM
Mar-12-25 03:03AM
Mar-11-25 07:30AM
Mar-04-25 08:00AM
Feb-24-25 08:00AM
Feb-17-25 09:15AM
Feb-05-25 05:59PM
Jan-22-25 09:15AM
07:39AM
Jan-15-25 12:20PM
09:55AM
Dec-26-24 09:40AM
Dec-13-24 08:15AM
Dec-12-24 08:00AM
Nov-20-24 08:00AM
Nov-12-24 07:30AM
Nov-11-24 07:13AM
Oct-31-24 09:40AM
Oct-29-24 08:00AM
Oct-21-24 09:55AM
09:15AM
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut in 2003 and is headquartered in Jerusalem, Israel.
Chief Executive OfficerMr. Hadar Levy
Co-Founder & Vice-ChairmanDr. David Zacut M.D.
Co-FounderProf. Abraham Zangen Ph.D.
Chief Financial OfficerMr. Ido Marom
Vice President of Medical AffairsDr. Colleen Hanlon Ph.D.